We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Routine Diagnostic Test for Lemierre Syndrome Is Required

By LabMedica International staff writers
Posted on 09 Dec 2009
Physicians when diagnosing sore throat, or pharyngitis, in adolescents and young adults must consider the newly identified, potentially dangerous Fusobacterium necrophorum as the source of infection. More...
The bacterium can cause Lemierre syndrome, a potentially dangerous condition.

Symptoms of Lemierre syndrome include unilateral neck swelling, rigors, night sweats, or high fevers. Currently there is no routine test for F. necrophorum pharyngitis, and a CT scan is required to detect Lemierre syndrome. In the event that the disease is diagnosed, aggressive treatment with antibiotics such as a combination of penicillin and metronidazole or with clindamycin alone is appropriate.

Lemierre syndrome mostly affects adolescents and young adults and rarely is seen in preadolescents. It begins with a sore throat, followed by an infected jugular vein after four to five days. Abscesses in other parts of the body may occur. Approximately 5 percent of people who get Lemierre syndrome die.

Physicians are trained to suspect group A streptococcal bacteria as the primary cause of pharyngitis. But according to findings by investigators at the University of Alabama at Birmingham (UAB; USA), and published on December 1, 2009 in the Annals of Internal Medicine, sore throat in young adults and adolescents that worsens or is strep-negative, could be due to F. necrophorum. Although group A strep. is associated with rheumatic fever, the incidence and rate of Lemierre syndrome following exposure to F. necrophorum is much higher and associated with greater morbidity and mortality.

Robert Centor, M.D., professor of internal medicine, associate dean of medicine at UAB and the paper's lead author, said, "F. necrophorum, which only has been recognized as a potential cause of pharyngitis in adolescents and young adults in the past five years, may cause up to 10 percent of sore throat in those 15-24 years of age. More important, F. necrophorum is associated with a rare but life-threatening complication called Lemierre syndrome."

Prof. Centor added that he hopes this analysis will lead to better diagnostic tests for the presence of F. necrophorum.

Related Links:

University of Alabama at Birmingham



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.